Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Huitian Biological Pharmaceutical is a comprehensive pharmaceutical enterprise based in Beijing, China, specializing in the research, development, production, and sale of chemical drugs and traditional Chinese medicines. Founded in 1994, the company operates a large-scale manufacturing base in the Daxing District with multiple GMP-certified production lines for tablets, capsules, and granules. Its extensive product portfolio addresses various therapeutic needs, including cardiovascular health, respiratory diseases, and metabolic disorders. The company is well-known for its high-volume production of essential medicines such as Metformin and Nifedipine, serving a broad patient base across China. Huitian integrates modern pharmaceutical technology with traditional medicine to provide a diverse range of healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 汇天生物药业.